Kelsey E Sivick

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Transcription Factor

Regulatory T Cells

Top Venues

Cancer research

Nature chemical biology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Dana Piovesan, Amber E de Groot, Soonweng Cho, Amy E Anderson, Rebecca D Ray, Amita Patnaik, Paul G Foster, Casey G Mitchell, Alejandra Y Lopez Espinoza, Wandi S Zhu, Carlo E Stagnaro, Hema Singh, Xiaoning Zhao, Lisa Seitz, Nigel P C Walker, Matthew J Walters, Kelsey E Sivick
Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity without Depleting Regulatory T Cells. Cancer research 84 (12) (2024)
Dana Piovesan, Amber E de Groot, Soonweng Cho, Amy E Anderson, Rebecca D Ray, Amita Patnaik, Paul G Foster, Casey G Mitchell, Alejandra Y Lopez Espinoza, Wandi S Zhu, Carlo E Stagnaro, Hema Singh, Xiaoning Zhao, Lisa Seitz, Nigel P C Walker, Matthew J Walters, Kelsey E Sivick
Fc-silent anti-TIGIT antibodies potentiate anti-tumor immunity without depleting regulatory T cells. Cancer research (2024)
Jie Li, Stephen M Canham, Hua Wu, Martin Henault, Lihao Chen, Guoxun Liu, Yu Chen, Gary Yu, Howard R Miller, Viktor Hornak, Scott M Brittain, Gregory A Michaud, Antonin Tutter, Wendy Broom, Mary Ellen Digan, Sarah M McWhirter, Kelsey E Sivick, Helen T Pham, Christine H Chen, George S Tria, Jeffery M McKenna, Markus Schirle, Xiaohong Mao, Thomas B Nicholson, Yuan Wang, Jeremy L Jenkins, Rishi K Jain, John A Tallarico, Sejal J Patel, Lianxing Zheng, Nathan T Ross, Charles Y Cho, Xuewu Zhang, Xiao-Chen Bai, Yan Feng
Activation of human STING by a molecular glue-like compound. Nature chemical biology (2023)
Dana Piovesan, Joanne B L Tan, Annette Becker, Jesus Banuelos, Nell N Narasappa, Daniel DiRenzo, Kristen Zhang, Ada Chen, Elaine Ginn, Akshata R Udyavar, Fangfang Yin, Susan L Paprcka, Bhamini Purandare, Timothy W Park, Nikki Kimura, Jaroslaw Kalisiak, Stephen W Young, Jay P Powers, Uli Schindler, Kelsey E Sivick, Matthew J Walters
Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity. Molecular cancer therapeutics 21 (6) (2022)